BDX : Summary for Becton, Dickinson and Company C - Yahoo Finance

U.S. Markets open in 2 hrs 26 mins

Becton, Dickinson and Company (BDX)

NYSE - NYSE Real Time Price. Currency in USD
Add to watchlist
164.75+0.34 (+0.21%)
At close: 4:01 PM EST
People also watch:
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close164.41
Bid160.00 x 500
Ask164.70 x 600
Day's Range162.07 - 165.55
52 Week Range129.50 - 181.76
Avg. Volume1,075,376
Market Cap34.98B
PE Ratio (TTM)36.69
Earnings DateN/A
Dividend & Yield2.92 (1.76%)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • These 3 Stocks Just Raised Their Dividends
    Motley Fool18 hours ago

    These 3 Stocks Just Raised Their Dividends

    Two Dividend Aristocrats make the list in this edition of our series.

  • PR Newswire2 days ago

    BD Integrating Technology, Expertise and Services to Provide Comprehensive Medication Management

    LAS VEGAS, Dec. 5, 2016 /PRNewswire/ -- BD (Becton, Dickinson and Company) (BDX), a leading global medical technology company, will demonstrate an enhanced technology platform designed with the ability to synchronize BD medication management technologies, including the company's leading Pyxis™ and Alaris™ systems, at this year's American Society of Health-System Pharmacists (ASHP) 2016 Midyear Meeting being held in Las Vegas from Dec. 4-8. While national data show that approximately 68 percent of medication errors occur during the administration phase, errors can happen during any step of the medication management processi. During last year's ASHP Midyear Meeting, BD revealed how its strong portfolio of solutions can help improve the safety and cost of healthcare during each step of the process.

  • PR Newswire6 days ago

    BD Announces Pricing of Tender Offers

    FRANKLIN LAKES, N.J., Dec. 1, 2016 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) (the " Company ") today announced the consideration payable in connection with its previously ...